BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21880209)

  • 1. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines.
    Angelini A; Centurione L; Sancilio S; Castellani ML; Conti P; Di Ilio C; Porreca E; Cuccurullo F; Di Pietro R
    J Biol Regul Homeost Agents; 2011; 25(2):203-11. PubMed ID: 21880209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
    Angelini A; Di Pietro R; Centurione L; Castellani ML; Conti P; Porreca E; Cuccurullo F
    J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
    Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
    J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs.
    Angelini A; Iezzi M; Di Febbo C; Di Ilio C; Cuccurullo F; Porreca E
    Oncol Rep; 2008 Oct; 20(4):731-5. PubMed ID: 18813811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
    Angelini A; Ciofani G; Conti P
    J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
    Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
    J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
    Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
    Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells.
    Takeshita A; Inagaki K; Igarashi-Migitaka J; Ozawa Y; Koibuchi N
    J Endocrinol; 2006 Sep; 190(3):897-902. PubMed ID: 17003290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells.
    Wang E; Lee MD; Dunn KW
    J Cell Physiol; 2000 Aug; 184(2):263-74. PubMed ID: 10867652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening.
    Wesolowska O; Paprocka M; Kozlak J; Motohashi N; Dus D; Michalak K
    Anticancer Res; 2005; 25(1A):383-9. PubMed ID: 15816562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
    Traunecker HC; Stevens MC; Kerr DJ; Ferry DR
    Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma.
    Warmann SW; Heitmann H; Teichmann B; Gratz KF; Ruck P; Hunger M; Fuchs J
    Pediatr Hematol Oncol; 2005; 22(5):373-86. PubMed ID: 16020127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.
    Hung TH; Chen CM; Tseng CP; Shen CJ; Wang HL; Choo KB; Chong KY
    Int J Biochem Cell Biol; 2014 Aug; 53():55-65. PubMed ID: 24814288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
    Hua J; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
    Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
    Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5.
    Choi JS; Kang NS; Min YK; Kim SH
    Phytother Res; 2010 Jul; 24(7):1042-6. PubMed ID: 19960428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.
    Park S; James CD
    Cancer Res; 2003 Feb; 63(3):723-7. PubMed ID: 12566319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.